Dana Blankenhorn

Dana Blankenhorn

Expertise: Technology, Biotech, Renewable energy

Education: M.S,J. Northwestern (Medill School) 1978; B.A. Rice University, History and Political Science 1977

Awards & Accomplishments: Tech reporter since 1982, Freelance since 1983, on Internet since 1985. Created first online coverage of Internet with a magazine, Interactive Age, 1994 Co-wrote BBS Systems for Business in 1991, Wrote Guide to Field Computing in 1992 Wrote technology history now called "Living with Moore's Law" in 2001, 2010, 2021 Author of over a dozen books, both fiction and non-fiction

About Dana:
Dana Blankenhorn has been a financial journalist since 1978, a technology journalist since 1982, and an Internet journalist since 1985. He writes a Substack newsletter, Facing the Future, which covers technology, markets, and politics.

He has written a half-dozen technology books, several novels available at the Amazon Kindle store, and covered beats ranging from education to e-commerce, and from open source to renewable energy. He lives in Atlanta.

Recent Articles

Is Costco Wholesale Corporation (COST) Stock Buy-Worthy Yet?

Costco lost nearly $20 per share after Amazon said it would buy Whole Foods, but was the reaction in COST stock overdone?

Why CVS Health Corp (CVS) Stock Will Win BIG With Trumpcare

CVS stock should win big as the company offers simple services that should become the healthcare choice of those losing coverage under Trumpcare.

Asia Is Winning the Fintech Game

Fintech products like mobile wallets and cloud-based banks are more popular in Asia than the U.S., thanks to startups and government action.

Healthcare Stocks Make a Dumb Move on ‘Trumpcare’

The Senate bill guts the move toward managed care, yet healthcare stocks are rising? Something's not right here.

Does Valeant Pharmaceuticals Intl Inc (VRX) Stock Have a Bull Case?

Valeant Pharamceutical has cleared enough assets to take immediate bankruptcy off the table, which is helping VRX stock normalize.